Altamir - 2018 Registration document

1

Business description and activities

Presentation of the Company

1.2.3 PORTFOLIO

For the year ended 31 December 2018

Percentage interest in the underlying operating company

Investment date

Residual cost (in €K)

Stage of development

TMT (Technologies – Media – Telecom)

Marlink (1a) (2) InfoVista (1a) (2)

2016 2016 2008 2018 2016 2018 2011 2017 2018 2017 2018 2017 2016 2015 2016 2015 2015

27.21% 21.48% 3.60% 17.30% 28.07% 18.45% 17.10% 2.25% 0.85% 1.39% 1.39% 1.70% 0.49% 0.96% 0.57% 0.22% 0.50%

70,261 39,240 38,932 36,294 33,744 31,078 10,677 8,379 4,343 4,065 3,236 2,556 2,337 2,336

LBO LBO

Altran Technologies * (3)

Growth capital

Expereo (1a)

LBO LBO LBO LBO LBO LBO LBO LBO LBO LBO LBO LBO LBO

Melita (1a)

Bip (1a)

Vocalcom (1a)

13,594 Growth capital

ThoughtWorks (1b) (2)

Paycor

ECi Software Solutions (1b)

Genius Sports Group

Attenti (1b)

Engineering Ingegneria Informatica (1b)

Exact Software (1b)

Duck Creek Technologies (1b)

Zensar * (1b) EVRY * (1b)

1,126 955

303,153

Healthcare

Amplitude Surgical * (1a)

2011 2017 2017 2016 2013 2018 2016 2017 2015

13.18% 1.03% 1.62% 0.96% 0.33% 1.67% 0.87% 1.42% 0.63%

14,041 9,646 5,345 2,077 3,619 3,169 2,874 2,841

LBO LBO LBO LBO LBO LBO LBO LBO LBO

Unilabs (1b) Candela (1b)

Vyaire Medical (1b)

One Call Care Management (1b)

Healthium MedTech (1b)

Neuraxpharm (1b) (formerly NuPharm365)

Kepro (1b)

Ideal Protein (1b)

150

46,502

(1) Investments in the Apax funds.

1a) via the Apax France VIII and Apax France IX. 1b) via the Apax VIII LP and Apax IX LP. (2) Co-investments (alongside the Apax France VIII, Apax France IX and Apax IX LP funds). (3) Co-investments (legacy portfolio). * Listed company.

22 Registration document ALTAMIR 2018

www.altamir.fr